8 155 ( Fig. 4) . Significant anti-NetB responses were observed in the splenocytes of birds 156 receiving the triple antigen strain (P < 0.05), but not in lymphocytes. Birds immunized 157 with the strain producing two antigens, PlcC and NetB, produced significant anti-NetB 158 responses in splenocytes (P < 0.005) and significant anti-PlcC responses in 159 lymphocytes (P < 0.05). Birds immunized with the strain producing Fba alone exhibited 160 significant cellular responses in splenocytes (P < 0.0001), while the response in 161 lymphocytes was not significant. 168 lesions using a 6 point scoring system [11] . In experiment 1, birds immunized with 169 either the double antigen strain or the triple antigen strain had significantly lower lesion 170 scores than birds in the control groups (Table 1) . There was no statistical difference 171 between the average lesion scores for the triple antigen and double antigen strain 172 groups (P = 0.25) in this experiment. In experiment 3, we included a strain producing only Fba in addition to the strains 182 evaluated in experiment 1. Chickens immunized with any strain carrying C. perfringens 183 antigens had significantly lower lesion scores than non-vaccinated or Salmonella only 184 controls ( Table 2) , indicating protection against C. perfringens challenge. As in the 185 previous experiment, there were no statistical differences between the double antigen 186 and triple antigen groups (P = 0.19). However, there was a significant difference in 187 lesion scores between the Fba-only group and the double antigen group (P = 0.01),
188 indicating that Fba is contributing to protection against C. perfringens challenge. 235 As controls, we included wells in which either NetB or the Streptococcus pneumoniae 236 protein PspA was substituted for Fba. Prior addition of Fba to the wells resulted in a 237 significant reduction in adherence (P < 0.037) ( Fig. 6) . We also found that NetB 257 and Neisseria meningitidis [17] . Our immunofluorescence data shows that a protein 258 cross-reactive with anti-Fba antisera is present on the surface of C. perfringens (Fig. 5) ,
259 a result consistent with a possible role for Fba as an adhesin in this organism. Our 260 tissue culture results support this as well, as adherence to Caco-2 cells is inhibited in 261 the presence of rFba (Fig. 6) . However, the importance of this finding will need to be 262 confirmed using a chicken epithelial cell line. Similarly, NetB appears to aid in 263 adherence to epithelial cells. This is not surprising, since NetB is known to be toxic to 277 strain elicited the strongest protection, significantly better than the vaccine delivering the 278 two toxoid antigens ( Table 2) . It is possible that, despite the careful strain design to 279 prevent loss of immunogenicity due to antigen load, there is some stress on the vaccine 280 strain delivering the two toxoid antigens, leading to lower immune responses against 281 each antigen. However, in the triple antigen strain, this deficiency appears to be offset 282 by the combined protective efficacy provided by each antigen. Although immunization 283 with the strain delivering Fba alone yielded the lowest lesion scores, it is likely that the 284 triple antigen strain will provide the broadest protection. This question will be examined 285 in future experiments.
286
It is of interest that, in this study, we achieved anti-Fba serum IgY titers similar to 287 the serum titers observed when Fba was delivered by a non-lysis strain [22] .
288 Conversely, delivery by lysis strain elicited much greater mucosal responses, indicating 289 that mucosal immunity is more important than humoral immunity for protection against 290 challenge.
291
Previous work demonstrated that anti-PlcC antibodies bound to the surface of C.
292 perfringens, indicating the presence of -toxin [7]. We extended those observations to 293 confirm that antibody binding did not occur in a plc mutant and that binding is reduced 294 by incubation of antisera with purified PlcC (Fig. 5) . Our data also indicate that NetB 295 toxin is present on the surface of C. perfringens. The presence of all three antigens on 296 the cell surface suggests that the anti-C. perfringens mucosal antibodies elicited by our 297 vaccine may bind directly to C. perfringens, facilitating opsonization and/or inhibiting 298 toxin secretion. If, as our data suggest, Fba serves as an adhesin for C. perfringens, 299 anti-Fba antibodies bound to C. perfringens cells may serve to prevent close contact of 15 300 the bacterium with the host epithelium, an important step in pathogenesis [23, 24] . In 301 addition, anti-PlcC antibodies were previously shown to inhibit C. perfringens growth 302 directly, suggesting another mechanism for the action of these antibodies.
303
This work highlights the potential for a Salmonella-vectored vaccine to control 304 NE. Our findings show that the Salmonella lysis vector strain 11802 was capable of 305 delivering up to three antigens simultaneously, generating humoral, cellular and 306 mucosal responses against all antigens. In particular, this strain is able to generate 307 strong mucosal responses as shown here and in a previous study [4] . Our results also 308 support the idea that intestinal mucosal responses are an effective deterrent against 315 Bacterial strains, plasmids and growth conditions. Strains and plasmids used in 316 this study are listed in 
